Progesterone, Training, and Exercise: What Your Levels Mean for Performance and Recovery

What high-volume training does to the reproductive axis

In a 1985 study, six eumenorrheic runners training at least 32 km a week and four sedentary women had LH measured over six hours in the early follicular phase; LH pulse frequency, amplitude and area under the curve were all significantly lower in the runners, suggesting central inhibition of the hypothalamic-pituitary-gonadal axis [1]. That study measured LH, not progesterone.

The American College of Sports Medicine's 2007 position stand states that low energy availability appears to impair reproductive and skeletal health in the female athlete triad, with most effects appearing below 30 kcal per kg of fat-free mass per day [5].

Cycle phase, heat and endurance

A 2003 review found that when hormone concentrations were verified, cycle phase did not change muscle contractile characteristics, and most determinants of VO2max did not change either. The author concluded that regularly menstruating athletes in strength sports and in intense anaerobic or aerobic sports do not need to adjust for cycle phase to maximize performance [2]. For prolonged exercise, the review says the cycle may have an effect: several studies report higher cardiovascular strain during moderate exercise in the mid-luteal phase, and time to exhaustion during prolonged exercise in hot conditions decreased [2]. The review also notes high between-person and within-person variability in estrogen and progesterone concentrations, which can obscure possible effects [2].

If you take oral progesterone

Prometrium is micronized progesterone in 100 mg and 200 mg oral capsules, labeled for preventing endometrial hyperplasia in postmenopausal women with a uterus who take conjugated estrogens tablets, and for secondary amenorrhea [3].

The label warning most relevant to training is drowsiness: it says Prometrium 'may cause transient dizziness and drowsiness and should be used with caution when driving a motor vehicle or operating machinery,' and is taken as a single daily dose at bedtime [3][4]. In the label's 3-year trial of Prometrium 200 mg plus conjugated estrogens versus placebo, dizziness was reported by 15% versus 9%; the active arm also took estrogen, so this cannot be assigned to progesterone alone [4]. The capsules contain peanut oil, and the label lists peanut allergy as a contraindication [3].

The current label has no boxed warning; FDA approved removal of the cardiovascular, breast cancer and probable dementia boxed-warning language for six menopausal hormone therapy products on 12 February 2026 [4][6].